Tsz H. So
Sar, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population.
Journal: NPJ precision oncology
Published: June 13, 2025
Acupuncture for insomnia in patients with breast cancer undergoing chemotherapy: a randomised sham-controlled trial (abridged secondary publication).
Journal: Hong Kong medical journal = Xianggang yi xue za zhi
Published: March 04, 2025
Case report: Low-dose radiation reverses pembrolizumab resistance in melanoma.
Journal: Frontiers in oncology
Published: August 19, 2024
Effects of puerarin supplementation on cardiovascular disease risk factors: a randomised, double-blind, placebo-controlled, two-way crossover trial (abridged secondary publication).
Journal: Hong Kong medical journal = Xianggang yi xue za zhi
Published: September 10, 2023
A systematic review to summarize treatment patterns, guidelines, and characteristics of patients with renal cell carcinoma in the Asia-Pacific region.
Journal: Expert review of anticancer therapy
Published: July 17, 2023
Acupuncture for chemotherapy-associated insomnia in breast cancer patients: an assessor-participant blinded, randomized, sham-controlled trial.
Journal: Breast cancer research : BCR
Published: November 10, 2022
Electroacupuncture Plus Auricular Acupressure on Chemotherapy-Related Insomnia in Patients With Breast Cancer (EACRI): Study Protocol for a Randomized, Sham-Controlled Trial.
Journal: Integrative cancer therapies
Published: November 22, 2021
Electroacupuncture Plus Auricular Acupressure for Chemotherapy-Associated Insomnia in Breast Cancer Patients: A Pilot Randomized Controlled Trial.
Journal: Integrative cancer therapies
Published: May 26, 2021
The Adjunctive Effect of Acupuncture for Advanced Cancer Patients in a Collaborative Model of Palliative Care: Study Protocol for a 3-Arm Randomized Trial.
Journal: Integrative cancer therapies
Published: May 07, 2021
Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failure.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 29, 2021
A Cost-Effectiveness Analysis of Systemic Therapy for Metastatic Hormone-Sensitive Prostate Cancer.
Journal: Frontiers in oncology
Published: November 08, 2020
Last Updated: 09/26/2026